A clinical trial to study efficacy of high dose of oral and parenteral Amoxycillin-Clavunate in severe pneumonia in chidren under five years of age.
Phase 4
Completed
- Conditions
- Health Condition 1: null- Children with severe pneumonia aged 2-59 months.
- Registration Number
- CTRI/2010/091/000341
- Lead Sponsor
- Dr Sadbhavna Pandit
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 165
Inclusion Criteria
Patients in age group 2-59 months with a diagnosis of Severe Pneumonia.
Severe pneumonia defined as Fever,Cough,Fast breathing (Respiratory rate more than 50 in age group 2-12 months and > 40 in 12-59 months) and Chest Indrawing.
Exclusion Criteria
Inability to take orally
Bronchial Asthma
Allergy to Penicillin
Very Severe Pneumonia
Grade3,4 PEM
Pleural Effusion
Congenital Heart Disease
Tuberculosis
Shock
Immunocompromised Patients
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method